[1] Linscott, A.J. and Brown, W.J. (2005) Evaluation of Four Commercially Extended Spectrum Beta-Lactamases Phenotypic Confirmatory Tests. Journal of Clinical Microbiology, 43, 1081-1085.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1081251/
https://doi.org/10.1128/JCM.43.3.1081-1085.2005
[2] Bradford, P.A. (2001) Extended-Spectrum β-Lactamase in 21st Century: Characterization, Epidemiology and Detection of This Important Rasistance Threat. Clinical Microbiology Reviews, 14, 933-951.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC89009/
https://doi.org/10.1128/CMR.14.4.933-951.2001
[3] Lin, C.-F., Hsu, S.-K., Chen, C.-H., Huang, J.-R. and Lo, H.-H. (2010) Genotypic Detection and Molecular Epidemiology of Extended Expectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumonia in a Regional Hospital in Central Taiwan. Journal of medical Microbiology, 59, 665-671.
https://www.ncbi.nlm.nih.gov/pubmed/20150317
https://doi.org/10.1099/jmm.0.015818-0
[4] Colodner, R., Reznik, B., Gal, V., Yamazaki, H., Hanaki, H. and Kubo, R. (2006) Evaluation of a Novel Kit for the Rapid Detection of Extended-Spectrum Beta-Lactamases. European Journal of Clinical Microbiology and Infectious Diseases, 25, 49-51.
https://doi.org/10.1007/s10096-005-0074-y
[5] National Committee for Clinical Laboratory Standards (1999) Performance Standards for Antimicrobial Susceptibility Testing. NCCLS Approved Standard, M100-S9, National Committee for Clinical Laboratory Standards, Wayne.
https://www.scirp.org/(S(i43dyn45teexjx455qlt3d2q))/reference/ReferencesPapers.aspx?ReferenceID=1145440
[6] Karim, A. and Parvez (2002) Emerging Multi-Drug Resistant Organism in Tertiary Care Hospital of Dhaka City. Bangladesh Journal of Medical Science, 8, 53-57.
[7] Thomson, K.S. Controversies about Extended-Spectrum and AmpC Beta-Lactamases’ Special Issue. 1-16.
[8] Alim, R. (2005) Detection of Extended Spectrum β-Lactamase (ESBL) Producing Bacteria. Thesis, BSMMU.
[9] Rahman, M., Haq, J.A., Hossain, M.A., Sultana, R., Islam, F. and Islam, S. (2004) Prevelance of Extended-Spectrum b-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in an Urban Hospital in Dhaka, Bangladesh. Antimicrobial Agents, 24, 508-510.
https://www.ncbi.nlm.nih.gov/pubmed/15519486
[10] Foury and Araj, G.F. (2003) Recent Developments in β-Lactamases and Extended Sepectrum β-Lactamases. Bangladesh Medical Journal, 327, 1209-1213.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC274061/
[11] Chlebicki, M.P. and Oh, H.M. (2004) Extended-Spectrum Beta-Lactamases in Clinical Isolates of Escherichia coli and Klebsiella spp. in a Singapore Hospital. Annals Academy of Medicine Singapore, 33, 302-306.
https://www.ncbi.nlm.nih.gov/pubmed/15175768
[12] Podschun, R. and Ullmann (1998) Klebsiella spp., as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clinical Microbiology Reviews, 11, 589-603.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88898/
https://doi.org/10.1128/CMR.11.4.589
[13] Consensus Guidelines for Management of Infections by ESBL-Producing Bacteria, Ministry of Health Malaysia, Academy of Medicine of Malaysia, Malaysian Society of Infectious Diseases and Chemotherapy, 2001.
[14] Bush, K., Jacoby, G.A. and Medeiros, A.A. (1995) A Functional Classification Scheme for β-Lactamases and Its Correlation with Molecular Structure. Antimicrob Agents Chemotherapy, 39, 1211-1233.
https://www.ncbi.nlm.nih.gov/pubmed/7574506